Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men (MENCount)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01694121 |
|
Recruitment Status :
Completed
First Posted : September 26, 2012
Results First Posted : December 28, 2018
Last Update Posted : December 28, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| HIV | Behavioral: MEN Count Behavioral: Comparison | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 455 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men |
| Actual Study Start Date : | March 2013 |
| Actual Primary Completion Date : | April 2017 |
| Actual Study Completion Date : | May 2018 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: MEN Count
3 session HIV intervention including a) HIV risk reduction, inclusive of gender equity and healthy relationship counseling and b) case management support for stable employment and housing.
|
Behavioral: MEN Count
The MEN Count model integrates HIV risk reduction and gender-equity counseling with housing and employment case management via multiple one-on-one sessions delivered by a peer case manager over 60-90 day period. |
|
Active Comparator: Comparison
An attention comparison program similar to the MEN Count intervention in structure (3 one-on-one sessions delivered over 60-90 days) but focused on stress reduction and healthy lifestyle.
|
Behavioral: Comparison
general health intervention for men, not inclusive of HIV or relationship health |
- Condom Use/Unprotected Sex - Redefined as Sexual Risk - 12 Month Follow-up [ Time Frame: 12 month follow-up ]Behavioral assessment of the ratio of protected to total number of sex episodes -- changed to sexual risk inclusive of inconsistent condom use in past 90 days + multiple sex partners + sex trade involvement. Very low sexual risk was defined as having one partner and consistent condom use. Low sexual risk was defined as having multiple partners and consistent condom use OR one partner and no/inconsistent condom use. Medium sexual risk was defined as having multiple partners, no/inconsistent condom use and not participating in transactional sex. High risk was defined as having multiple partners, no/inconsistent condom use, and participating in transactional sex. Participants reporting sex with men in the prior 90 days or who reported that they themselves or (one of) their partner(s) was HIV-positive were excluded from the sexual risk outcome given the known differential HIV risk profile for these subpopulations and small numbers of participants in each.
- Condom Use/Unprotected Sex - Redefined as Sexual Risk - 6 Month Follow-up [ Time Frame: 6 month follow-up ]Behavioral assessment of the ratio of protected to total number of sex episodes -- changed to sexual risk inclusive of inconsistent condom use in past 90 days + multiple sex partners + sex trade involvement. Very low sexual risk was defined as having one partner and consistent condom use. Low sexual risk was defined as having multiple partners and consistent condom use OR one partner and no/inconsistent condom use. Medium sexual risk was defined as having multiple partners, no/inconsistent condom use and not participating in transactional sex. High risk was defined as having multiple partners, no/inconsistent condom use, and participating in transactional sex. Participants reporting sex with men in the prior 90 days or who reported that they themselves or (one of) their partner(s) was HIV-positive were excluded from the sexual risk outcome given the known differential HIV risk profile for these subpopulations and small numbers of participants in each.
- Non-viral STI - 12 Month Follow-up [ Time Frame: 12 month follow-up ]HIV and STI testing via blood and urine tests was conducted; outcome based on non-viral STI to allow for incidence assessment and change over time
- Non-viral STI - 6 Month Follow-up [ Time Frame: 6 month follow-up ]HIV and STI testing via blood and urine tests was conducted; outcome based on non-viral STI to allow for incidence assessment and change over time
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 40 Years (Adult) |
| Sexes Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria: Black men aged 18 and older, reporting heterosexual risk for HIV [unprotected sex with a woman and 2+ female sex partners in the past 6 months] and either current unemployment or homeless in the past 6 months.
Exclusion Criteria: planned to leave Washington D.C., Maryland, or Virginia in the next 6 months, were cognitively impaired (based on Folstein Mini-Mental Exam at recruitment or baseline testing), and/or had self-reported health status that prohibited them from participating in the program
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01694121
| United States, District of Columbia | |
| George Washington University | |
| Washington, District of Columbia, United States, 20052 | |
| Principal Investigator: | Anita Raj, PhD | UCSD | |
| Principal Investigator: | Lisa Bowleg, PhD | George Washington University |
Documents provided by Anita Raj, University of California, San Diego:
| Responsible Party: | Anita Raj, Professor, University of California, San Diego |
| ClinicalTrials.gov Identifier: | NCT01694121 |
| Other Study ID Numbers: |
R01MH096657 ( U.S. NIH Grant/Contract ) |
| First Posted: | September 26, 2012 Key Record Dates |
| Results First Posted: | December 28, 2018 |
| Last Update Posted: | December 28, 2018 |
| Last Verified: | December 2018 |
|
HIV prevention African American men evaluation study |

